Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshitsugu Mitani
Frequent PTEN Loss and Differential HER2/PI3K Signaling Pathway Alterations in Salivary Duct Carcinoma: Implications for Targeted Therapy
Cancer
Cancer Research
Oncology
N-Terminal Truncated Myb With New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma
Cancers
Cancer Research
Oncology
Related publications
HER2 Signaling Modulates the Equilibrium Between Pro- And Antiangiogenic Factors via Distinct Pathways: Implications for HER2-targeted Antibody Therapy
Oncogene
Cancer Research
Genetics
Molecular Biology
Interleukin-6 Mediates Resistance to PI3K-pathway–targeted Therapy in Lymphoma
BMC Cancer
Cancer Research
Oncology
Genetics
PI3K/PTEN/Akt/mTOR Pathway Aberrations and Co-Incidence of Hormone Receptors and HER2 in 19,784 Diverse Solid Tumors.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
Cancer Research
Cancer Research
Oncology
Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer Through ROCK/PTEN/PI3K Signaling Pathway
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination
Journal of Immunology
Allergy
Immunology
